| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/19/2000 | EP1019063A1 Modulation of immune responses |
| 07/19/2000 | EP1019059A1 USE OF FXR, PPARalpha AND LXRalpha ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION |
| 07/19/2000 | EP1019057A1 A method of preventing or treating estrogen-dependent diseases and disorders |
| 07/19/2000 | EP1019052A1 Alpha 1a adrenergic receptor antagonists |
| 07/19/2000 | EP1019050A1 Use of somatostatin agonists and antagonists for treating diseases related to the eye |
| 07/19/2000 | EP1019047A1 Antithrombotic agents |
| 07/19/2000 | EP1019046A1 Protease inhibitors |
| 07/19/2000 | EP1019044A1 Composition and methods for treating alzheimer's disease and other amyloidoses |
| 07/19/2000 | EP1019042A1 Anti-first-pass effect compounds |
| 07/19/2000 | EP1019036A1 Use of d-methionine to reduce the toxicity of ototoxic drugs, noise, and radiation |
| 07/19/2000 | EP1019034A2 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 07/19/2000 | EP1019028A1 $i(CHLAMYDIA) PROTEIN, GENE SEQUENCE AND USES THEREOF |
| 07/19/2000 | EP1019010A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 07/19/2000 | EP0821682B1 Benzimidazole compounds and their use as modulators of the gaba-a receptor complex |
| 07/19/2000 | EP0674626B1 Selective aromatase inhibiting compounds |
| 07/19/2000 | EP0641355B1 Use of sulphamate derivatives as steroid sulphatase inhibitors |
| 07/19/2000 | EP0573565B1 Opiate receptor antagonist modulates hyperkinetic movement disorder |
| 07/19/2000 | CN1260833A LAG-3 splice variants |
| 07/19/2000 | CN1260802A 20-aralkyl-5 'alpha'-pregnane derivatives |
| 07/19/2000 | CN1260798A Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha 1-blocking action |
| 07/19/2000 | CN1260797A 3-substituted 3,4-dihydro-thieno (2,3-d) pyrimidine derivatives and preparation and use of same |
| 07/19/2000 | CN1260795A Quaternary ammonium compounds as tachykinin antagenists |
| 07/19/2000 | CN1260794A 5-aryl-3-(8-azabicyclo (3.2.2) oct-3-yl)-1,3,4-oxadiazol-2(3H)-one derivatives as -5HT4 receptor ligands |
| 07/19/2000 | CN1260791A 3-benzylpiperidine |
| 07/19/2000 | CN1260789A Heterocyclic compounds, method for preparing and medicine compositions containing same |
| 07/19/2000 | CN1260784A Quinoline derivatives as PDEIV and INF inhibitors |
| 07/19/2000 | CN1260782A Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors |
| 07/19/2000 | CN1260781A Indole derivatives having combined 5HT1A, 5HT1B and 5HT1D receptor antagoinist activity |
| 07/19/2000 | CN1260780A Ace-inhibitor nitric salts |
| 07/19/2000 | CN1260774A Method for producing medicines containing HMG-CoA-reductase inhibitors |
| 07/19/2000 | CN1260719A Treatment of diabetes with thiazolidinedione and sulphonylurea |
| 07/19/2000 | CN1260716A Treatment of diabetes with thiazolidinedione and metformin |
| 07/19/2000 | CN1260714A Controlled release pharmaceutical preparation with ACE inhibitor as active agent |
| 07/19/2000 | CN1260345A Hydrazide compound, its preparing method and medicine compositions thereof |
| 07/19/2000 | CN1260179A Nucleic acid oral powder and its production method |
| 07/19/2000 | CN1054599C Hydroxamic acid derivatives and preparation method and use |
| 07/19/2000 | CN1054527C Longshe instant powder for recovering one's health and preparation method |
| 07/19/2000 | CN1054519C Brain-tonifying and kidney-nourishing oral liquid |
| 07/19/2000 | CN1054514C Process for preparing compound health-care tea of Gynostemma pentaphyllum |
| 07/19/2000 | CN1054506C Pharmaceutical composition use |
| 07/18/2000 | US6090948 Inhibitors of farnesyl-protein transferase |
| 07/18/2000 | US6090942 Process and intermediates for a β3 -adrenergic receptor agonist |
| 07/18/2000 | US6090918 Polypeptide associated with the inhibition of prostaglandin biosynthesis and treating inflammation |
| 07/18/2000 | US6090914 CTLA4/CD28Ig hybrid fusion proteins and uses thereof |
| 07/18/2000 | US6090852 Matrix metalloprotease inhibitor |
| 07/18/2000 | US6090849 Carnitine supplemented diet to prevent sudden death syndrome in breeder type poultry |
| 07/18/2000 | US6090842 Reduces concentration of oxygen in cells |
| 07/18/2000 | US6090840 Peptidyl compounds having MMP and TNF inhibitory activity |
| 07/18/2000 | US6090837 Substituted hydrochromenopyrroles |
| 07/18/2000 | US6090825 Oxazole derivatives as antagonists of alpha 1C andrenergic receptors |
| 07/18/2000 | US6090824 Therapeutic neurokinin receptor antagonist compounds |
| 07/18/2000 | US6090818 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them |
| 07/18/2000 | US6090817 Respiratory system disorders; phosphodiesterse inhibitor |
| 07/18/2000 | US6090816 Antiasthma agents |
| 07/18/2000 | US6090813 Use of oxido-squalene cyclase inhibitors to lower blood cholesterol |
| 07/18/2000 | US6090796 Anticancer, antitumor agent; viricide |
| 07/18/2000 | US6090791 Method for inducing mucosal immunity |
| 07/18/2000 | US6090788 Irradiating the area of skin or nail with a light beam having at least one wavelength absorbable by the pathogen to destruct the fungal pathogen |
| 07/18/2000 | US6090782 Contacting hematopoietic cells with a stem cell proliferation inhibition amount of a peptide or polypeptide having specific amino acid sequence |
| 07/18/2000 | US6090618 DNA constructs and viral vectors comprising a smooth muscle promoter |
| 07/18/2000 | US6090612 Polynucleotide sequence coding a phosphatase enzymes; a diagnostic tool for monitoring enzyme activity in sample; for treatment of nervous system disorders, cardiovascular disorders and tumors; antitumor agents |
| 07/18/2000 | US6090585 Dna sequence; for treatment or prevention of connective tissue diseases related to metalloproteinases such as periodontal disease, corneal and skin ulcers, and rheumatoid arthritis; antitumor/anticarcinogenic/antimetastasis agents |
| 07/18/2000 | US6090583 Expression system in compatible host cell of a polynucleotide which produces a metalloprotease; diagnosis and treatment of asthma, disorders of leukotriene metabolism; anticarcinogenic agents; antiinflammatory/antidiabetic/antiarthritic agents |
| 07/18/2000 | US6090579 Human SDR2 cDNA clone |
| 07/18/2000 | US6090544 Screening for compounds capable of activating osteogenic protein-1-responsive transcription activating element by transforming cell with dna of element linked to reporter gene, exposing cell to compound, determining gene expression |
| 07/18/2000 | US6090542 Inhibiting the activity of nf-kb, a transcription factor, by treating the cells with a substance which specifically inhibits the proteolytic degradation of ikb-alpha |
| 07/18/2000 | US6090381 Stimulation of an immune response with antibodies labeled with the . .alpha-galactosyl epitope |
| 07/18/2000 | CA2183954C Treatment of obsessive-compulsive disorders with 5-ht2 antagonists |
| 07/18/2000 | CA2148651C Halogenated antifungal and antibacterial compounds used for reducing hair loss |
| 07/18/2000 | CA2093927C Ligand-mediated immunofunctional hormone binding protein assay method |
| 07/18/2000 | CA2017376C Diarylstyrylquinoline diacids |
| 07/18/2000 | CA2008616C Aryl- or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions |
| 07/18/2000 | CA2008183C Liquid pharmaceutical composition for piperidinoalkanol derivatives |
| 07/13/2000 | WO2000040740A2 Gene therapy to promote angiogenesis |
| 07/13/2000 | WO2000040733A1 Human cyclic nucleotide pdes |
| 07/13/2000 | WO2000040728A1 Nucleic acids and proteins corresponding to mutants of g-csf with granulopoietic activity |
| 07/13/2000 | WO2000040716A2 Soluble receptor br43x2 and methods of using them for therapy |
| 07/13/2000 | WO2000040714A2 Therapeutic phosphodiesterase inhibitors |
| 07/13/2000 | WO2000040699A2 Astrocytes, their preparation and uses thereof |
| 07/13/2000 | WO2000040693A2 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 07/13/2000 | WO2000040614A2 Characterization of the soc/crac calcium channel protein family |
| 07/13/2000 | WO2000040612A1 Insulin-like growth factor (igf) i mutant variants |
| 07/13/2000 | WO2000040600A1 Selective inhibitors of mmp-12 |
| 07/13/2000 | WO2000040597A1 Method and composition for angiogenesis inhibition |
| 07/13/2000 | WO2000040580A1 3,4-dihydro-2h-benzo[1,4]oxazinyl-methyl[3-(1h-indol-3-yl)-alkyl]-amines |
| 07/13/2000 | WO2000040576A2 Thiopyran compounds as inhibitors of mmp |
| 07/13/2000 | WO2000040574A1 1,4-diazacycloheptane compounds, process for their preparation, and their use as medicaments |
| 07/13/2000 | WO2000040571A1 Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor xa activity) |
| 07/13/2000 | WO2000040569A1 2-amino-benzoxazinone derivatives for the treatment of obesity |
| 07/13/2000 | WO2000040565A1 Tetrahydroindazole derivatives as ligands for gaba-a alpha 5 receptors |
| 07/13/2000 | WO2000040563A1 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
| 07/13/2000 | WO2000040561A1 Quinolinecarboxamides as antiviral agents |
| 07/13/2000 | WO2000040553A1 3-substituted pyrrolidines useful as inhibitors of matrix metallo-proteinases |
| 07/13/2000 | WO2000040552A1 Amidomalonamides and their use as inhibitors of matrix metalloproteinase |
| 07/13/2000 | WO2000040548A1 Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
| 07/13/2000 | WO2000040543A1 Skin whitener |
| 07/13/2000 | WO2000040539A1 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases |
| 07/13/2000 | WO2000040265A1 Potentiation of anti-cd38-immunotoxin cytotoxicity |
| 07/13/2000 | WO2000040263A1 Production and use of a composition containing ivig for treating diseases that are characterized by elevated extracellular fasl titers |
| 07/13/2000 | WO2000040258A1 Extracts of celery seed for the prevention and treatment of pain, inflammation and gastrointestinal irritation |